3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of Prostate
Sponsor: GE Healthcare
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from GE Healthcare
Other Prostate Cancer trials with similar outcome
This NA trial investigates Prostate Cancer and is currently terminated or withdrawn. GE Healthcare leads this study, which shows 11 recorded versions since 2007 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Mar 2020 — Jan 2021 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jun 2019 — Mar 2020 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
May 2019 — Jun 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Mar 2017 — Mar 2018 [monthly]
Recruiting NA
-
Feb 2017 — Mar 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GE Healthcare
- M.D. Anderson Cancer Center
- United States Department of Defense
For direct contact, visit the study record on ClinicalTrials.gov .